About Us
ETH Biotech spin-off based in Zurich
Our breakthrough technology
Evis Bioscience is pioneering a patented technology for targeted and safe delivery of nucleic acids using extracellular vesicles
Our Core Values
Driving innovation in gene therapy for treating genetic disorders
Evis Bioscience is pioneering a patented technology for targeted and safe delivery of nucleic acids using extracellular vesicles
Our breakthrough technology
ETH Biotech spin-off based in Zurich
Our Core Values
Driving innovation in gene therapy for treating genetic disorders
Team
Prof. Elita Montanari
Co-founder & CTO
Mr. Tommaso Caselli
Co-founder & Director
Dr. Raffaella Daniele
Research Scientist
Dr. Vincent Forster
Research & Business Advisor
Dr. Petra Wulfroth
Innosuisse Mentor
Innovative Gene Therapy Solutions
We offer hybrid platforms based on extracellular vesicles and lipid nanoparticles for delivering therapeutic nucleic acids
JOIN THE INNOVATION
Don’t miss out on our exciting journey!
Follow us on LinkedIn for all the latest updates and exclusive content.